Novocure
Lawrence Watt is a seasoned leader in clinical research and medical affairs, currently serving as the Lead Clinical Research Scientist at Novocure since August 2020. Prior to this role, Lawrence held significant positions at Merck, including Oncology Research Scientific Director and Oncology Medical Affairs Director, from September 2016 to August 2020. Lawrence's experience also includes serving as a Regional Medical Liaison for Solid Tumors at Celgene from November 2011 to September 2016, and as a Senior Medical Science Liaison at Sanofi from October 2004 to November 2011. Additionally, Lawrence worked as a Clinical Pharmacy Coordinator at Cancer Treatment Centers of America from January 2002 to October 2004. Educational qualifications include a Master of Business Administration (MBA) in Finance, Marketing, and Healthcare Management from Northwestern University - Kellogg School of Management, a Doctor of Pharmacy (Pharm.D.) from the University of California, San Francisco, and a Bachelor of Science in Animal Physiology from the University of California, Davis.
This person is not in the org chart
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.